JSE LIMITED - Dealings in securities by director, prescribed officers, and the JSE LTIS 2018 Trust

Dealings in securities by director, prescribed officers, and the JSE LTIS 2018 Trust

JSE LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 2005/022939/06
Share Code: JSE
ISIN Code: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
(“JSE”)

DEALINGS IN SECURITIES BY DIRECTOR, PRESCRIBED OFFICERS, AND THE JSE LTIS 2018 TRUST

The JSE LTIS 2018 Trust (“Trust”) has acquired 74 460 JSE ordinary shares
in the open market on behalf of an executive director and prescribed
officers (“LTIS 2018 participants”) to fulfil share awards granted in August
2022 to these LTIS 2018 participants under the JSE’s Long-Term Incentive
Scheme (“LTIS 2018”).

These ordinary shares are held in trust and are restricted until all vesting
criteria are fulfilled whereupon the shares vest in the hands of LTIS 2018
participants. To the extent that the vesting criteria are not fulfilled
the share awards are forfeited.

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) a LTIS 2018 participant remaining in the employ of the JSE for the
     vesting term (collectively “the vesting criteria”).

These JSE ordinary shares were acquired on-market, with prior clearance,
at a volume-weighted average price (“VWAP”) of R110.3277 per ordinary share.
The total transaction value amounted to R8 215 000. The daily high, low
and volume-weighted average price for the transactions effected by the Trust
were –

 Date in 2022   Number of JSE   Daily VWAP of   Daily highest   Daily lowest
 that JSE       ordinary        JSE shares      price paid      price paid
 ordinary       shares          acquired        (cents per      (cents per
 shares were    acquired        (cents per      share)          share)
 acquired                       share)

 30 August      74 460          11032.77        11100           10890

The requisite approvals have been granted by shareholders at the JSE’s
annual general meeting, in respect of the acquisition of JSE ordinary shares
in the open market and in respect of specific financial assistance to the
Trust for the purpose of acquiring these shares.

ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTOR AND PRESCRIBED OFFICERS

Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, the executive director and the prescribed officers have
on 30 August 2022 accepted grants of restricted JSE ordinary shares, as
reflected below.


 Executive     Role          Total number of   Total Rand value    Nature of
                             restricted JSE    of restricted JSE   interest
                             ordinary shares   ordinary shares
                             awarded and       awarded and
                             accepted          accepted

 L Fourie      Group CEO &   22 060            2 433 829           Direct
               Executive                                           beneficial
               Director
 A Greenwood   Prescribed    24 820            2 738 333           Direct
               Officer                                             beneficial
 V Reddy       Prescribed    27 580            3 042 838           Direct
               Officer                                             beneficial



The restricted shares will vest in two tranches, one-half on 1 March 2025
and the remaining half on 1 March 2026, subject to the vesting criteria as
set out above being met.

The individual allocations (grant and acceptance) were approved by the JSE’s
Group Remuneration Committee and clearance to deal was granted by the
Chairman of the Board.

Sandton
2 September 2022

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 02-09-2022 04:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.